Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients

Journal of the American Society of Nephrology

Volumn 12, Issue 1, 2001, Pages 170-176

  Thervet, E ^a   Anglicheau, D ^a   Toledano, N ^a   Houllier, A M ^a   Noel, L H ^a   Kreis, H ^a   Beaune, P ^a   Legendre, C ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE; METHYLTRANSFERASE;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG METABOLISM; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ACUTE DISEASE; BLOOD; ENZYME INDUCTION; ENZYMOLOGY; GRAFT REJECTION; PATHOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; SAFETY;

ACUTE DISEASE; ADULT; AZATHIOPRINE; ENZYME INDUCTION; ERYTHROCYTES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; METHYLTRANSFERASES; PROSPECTIVE STUDIES; SAFETY;

EID: 0034746977     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The collaborative transplant study
2. Maintenance therapy with triple versus double immunosuppressive regimen in renal transplantation: A meta-analysis
3. Azathioprine for long-term maintenance of remission in autoimmune hepatitis
4. Azathioprine and 6-mercaptopurine in Crohn disease: A meta-analysis
5. 6-thiopurines as substrates and inhibitors of purine oxidases: A pathway for conversion of azathioprine into 6-thiouric acid without release of 6-mercaptopurine
6. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine
7. Monitored high-dose azathioprine treatment reduces acute rejection episodes after renal transplantation
8. Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity
9. Thiopurine methyltransferase pharmacogenetics: Human gene cloning and characterization of a common polymorphism
10. A single mutation leading to loss of catalytic activity in human thiopurine-S-methyltransferase
11. Human thiopurine methyltransferase pharmacogenetics: Gene polymorphisms
12. Thiopurine S-methyltransferase
13. Thiopurine-methyl-transferase activity to assess azathioprine myelotoxicity in renal transplant recipients
14. Thiopurine methyl-transferase genotype predicts therapy-limiting severe toxicity from azathioprine
15. High incidence of secondary brain tumours after radiotherapy and antimetabolites
16. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
17. The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients
18. Monitoring of azathioprine-induced immunosuppression with thiopurine methyltransferase activity in kidney transplant recipients
19. The Banff 97 working classification of renal allograft pathology
20. Human erythrocyte thiopurine methyltransferase: Radiochemical microassay and biochemical properties
21. Expedient liquid chromatographic analysis of azathioprine in plasma by use of silica solid phase extraction
22. Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance
23. Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis
24. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: A report of the United States FK506 Study Group
25. Mycophenolate mofetil in cadaveric renal transplantation
26. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: Results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group
27. Glutathion S-transferase (GSSTTI) polymorphism is associated with acute rejection risk
28. Increased incidence of allograft rejection in stable heart transplant recipients after late conversion from mycophenolate mofetil to azathioprine